Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Claire Bournaud-Salinas"'
Publikováno v:
EJNMMI Physics, Vol 8, Iss 1, Pp 1-15 (2021)
Abstract Background Extravasation of radiopharmaceuticals used for vectorized internal radiotherapy can lead to severe tissue damage (van der Pol et al., Eur J Nucl Med Mol Imaging 44:1234–1243, 2017). Clinical management of these extravasations re
Externí odkaz:
https://doaj.org/article/899a21e2ade94e59a5dff2f65404af31
Publikováno v:
EJNMMI Physics, Vol 8, Iss 1, Pp 1-15 (2021)
Background Extravasation of radiopharmaceuticals used for vectorized internal radiotherapy can lead to severe tissue damage (van der Pol et al., Eur J Nucl Med Mol Imaging 44:1234–1243, 2017). Clinical management of these extravasations requires th
Autor:
Gilles Zah-Bi, Juliette Abeillon-du Payrat, Anne Laure Vie, Moncef Berhouma, Claire Bournaud-Salinas, Emmanuel Jouanneau
Publikováno v:
Neurosurgery. 85:E1059-E1067
BACKGROUND Dysthyroid optic neuropathy (DON) is a devastating complication of thyroid eye disease. Corticosteroids are the primary medical treatment for DON, but some refractory patients may require surgical management. OBJECTIVE To evaluate the effi
Autor:
Françoise Borson-Chazot, Michel Pugeat, Solène Castellnou, Myriam Decaussin-Petrucci, Jean-Louis Peix, Jean Christophe Lifante, Matthieu Bosset, Philippe Moulin, Agnes Perrin, Geneviève Sassolas, Maxime Bonjour, Zakia Hafdi-Nejjari, Claire Bournaud-Salinas
Publikováno v:
European Thyroid Journal
European Thyroid Journal, Karger, 2021, 10 (6), pp.486--494. ⟨10.1159/000510620⟩
Eur Thyroid J
European Thyroid Journal, Karger, 2021, 10 (6), pp.486--494. ⟨10.1159/000510620⟩
Eur Thyroid J
Introduction: Recent guidelines of the American Thyroid Association (ATA) suggest that a lobectomy may be sufficient to treat low- to intermediate-risk patients with thyroid tumors ≤40 mm, without extrathyroidal extension or lymph node metastases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b96922ae025006193a4d00c5a4535e5
https://doi.org/10.1159/000510620
https://doi.org/10.1159/000510620
Background. Extravasation of radiopharmaceuticals used for vectorized internal radiotherapy can lead to severe tissue damage (1). Clinical management of these extravasations requires the preliminary estimation of the dose distribution in the extravas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15d063173bea8373dfc3add52de89a43
https://doi.org/10.21203/rs.3.rs-57991/v1
https://doi.org/10.21203/rs.3.rs-57991/v1
Publikováno v:
EJNMMI Physics
Background Extravasation of radiopharmaceuticals used for vectorized internal radiotherapy can lead to severe tissue damage (van der Pol et al., Eur J Nucl Med Mol Imaging 44:1234–1243, 2017). Clinical management of these extravasations requires th
Autor:
Adélaïde Doussau, Alain Ravaud, Bogdan Catargi, Christelle De La Fouchardiere, Julien Asselineau, Claire Bournaud-Salinas, Patricia Nicolli-Sire, Anne Gimbert, Amaury Daste, Delphine Pedenon, Jean-Pierre Delord, Jean-Louis Wémeau, L. Digue, Patrice Rodien, Marie-Quitterie Picat, Christine Do Cao, Marc Klein, Damien Pouessel, Philippe Caron
Publikováno v:
European Journal of Cancer. 76:110-117
Purpose Patients with advanced radioactive iodine resistant differentiated (MDTC) or medullary (MMTC) thyroid cancer had an unmet need. Early data showed promising efficacy of vascular endothelial growth factor receptor inhibitors. We investigated su
Autor:
Armelle Delahaye, Françoise Borson Chazot, Christelle De La Fouchardiere, Jonathan Lopez, Myriam Decaussin-Petrucci, Jean-Louis Peix, Jean-Christophe Lifante, Sandrine Masson, Julien Berthiller, Anne-Laure Giraudet, Françoise Descotes, Claire Bournaud-Salinas
Publikováno v:
European journal of cancer (Oxford, England : 1990). 92
Background The prognosis of poorly differentiated thyroid carcinomas (PDTC) is heterogeneous though generally poor. The objectives of this study were to identify clinical and molecular factors of poor prognosis. Methods One hundred four consecutive p
Autor:
David Kryza, Anne Laure Giraudet, A. Moreau, Francesco Giammarile, Claire Bournaud-Salinas, Jean-Christophe Lifante, Claire Houzard, Françoise Borson-Chazot, Thomas Mognetti, Patrick Combemale
Publikováno v:
Clinical nuclear medicine. 42(5)
F-FDOPA is a well-established tool to explore pheochromocytomas. It tends to replace I-MIBG scan in metastatic pheochromocytomas, multiple endocrine neoplasia type 2-related tumors, succinate dehydrogenase [ubiquinone] iron-sulfur subunit-negative tu
Autor:
Nadia Oussaid, Myriam Decaussin-Petrucci, Claire Bournaud-Salinas, Anne-Laure Giraudet, Qing Wang, Jonathan Lopez, Jean-Louis Peix, Christelle De La Fouchardiere, Marie-Eve Fondrevelle, Jean-Christophe Lifante, Pierre-Paul Bringuier, Olfa Derbel, Françoise Borson-Chazot
Publikováno v:
Targeted oncology. 11(1)
Whether mutation status should be used to guide therapy is an important issue in many cancers. We correlated mutation profile in radioiodine-refractory (RAIR) metastatic thyroid cancers (TCs) with patient outcome and response to tyrosine kinase inhib